Skip to Main Content

Paper Details

Negligible impact of SARS-CoV-2 variants on CD4 [+] and CD8 [+] T cell reactivity in COVID-19 exposed donors and vaccinees.
bioRxiv
106
2021
B.1.1, B.1.351, CAL.20C as, CD4, CD4 +, CD4+, CD8 +, CD8+, CD8+ T cell, COVID-19, COVID-19 mRNA, P.1, SARS, SARS-, SARS-CoV, SARS-CoV-2, ancestral, mRNA-1273, variant lineages
Author NameAffiliation
John SidneyCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Davey M SmithUniversity of California, San Diego (university of california san diego)
Bjoern PetersCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Bjoern PetersUniversity of California, San Diego (university of california san diego)
Bjoern PetersCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Bjoern PetersUniversity of California, San Diego (university of california san diego)
Richard H ScheuermannCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Richard H ScheuermannUniversity of California
Richard H ScheuermannJ. Craig Venter Institute
Richard H ScheuermannCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Richard H ScheuermannJ. Craig Venter Institute
Richard H ScheuermannUniversity of California
Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Alessandro SetteUniversity of California, San Diego (university of california san diego)
Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Alessandro SetteUniversity of California, San Diego (university of california san diego)
  • 1 - 16

Datasets